Psoriasis and metabolic syndrome in children: current data.

Pietrzak, A; Grywalska, E; Walankiewicz, M; Lotti, T; Rolinski, J; Myslinski, W; Chabros, P; Piekarska-Myslinska, D; Reich, K

Pietrzak, A; Grywalska, E; Walankiewicz, M; Lotti, T; Rolinski, J; Myslinski, W; Chabros, P; Piekarska-Myslinska, D; Reich, K.

Afiliação

Pietrzak A; Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Lublin, Poland.
Grywalska E; Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland.
Walankiewicz M; St. John's Cancer Center, Lublin, Poland.
Lotti T; Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland.
Rolinski J; Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
Myslinski W; Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland.
Chabros P; St. John's Cancer Center, Lublin, Poland.
Piekarska-Myslinska D; Department of Internal Diseases, Medical University of Lublin, Lublin, Poland.
Reich K; Department of Dermatology, Venereology and Paediatric Dermatology, Medical University of Lublin, Lublin, Poland.

Clin Exp Dermatol ; 42(2): 131-136, 2017 Mar.

Article em En | MEDLINE | ID: mdl-28044372

Assuntos

HDL-Colesterol/sangue; Síndrome Metabólica/complicações; Psoríase/complicações; Glicemia; Criança; HDL-Colesterol/análise; Humanos; Síndrome Metabólica/epidemiologia; Prevalência; Psoríase/sangue; Triglicerídeos/sangue

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Síndrome Metabólica / HDL-Colesterol Tipo de estudo: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Child / Humans Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google